TYME - Tyme TechnologiesAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $1.33 | Open | |
| Volume | 222 | Market Cap | 199.55M |
| Yield | Last Dividend |
| Tyme Technologies, Inc. (NASDAQ:TYME) Ma... | 02/18/21 |
| Tyme Technologies, Inc. (NASDAQ:TYME) major shareholder Michael Demurjian sold 20,000 shares of the business???s stock in a transaction dated Tuesday,... | |
| Why Tyme Technologies Stock Is Taking Of... | 02/09/21 |
| The company closed a $100 million public stock offering. | |
| TYME Announces Closing of $100 Million R... | 02/08/21 |
| BEDMINSTER, N.J.--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-ba... | |
| Tyme Technologies (NASDAQ:TYME) Issues Q... | 02/06/21 |
| Tyme Technologies (NASDAQ:TYME) announced its quarterly earnings data on Thursday. The company reported ($0.05) EPS for the quarter, beating analysts?... | |
| TYME Provides Business Update and Announ... | 02/04/21 |
| BEDMINSTER, N.J.--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-ba... | |
| TYME Announces $100 Million Registered D... | 02/04/21 |
| BEDMINSTER, N.J.--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-ba... | |
| Tyme Technologies skyrockets 120% after ... | 02/03/21 |
| Summary List Placement Tyme Technologies skyrocketed as much as 127% on Wednesday after the company announced the US Patent and Trademark Office grant... | |
| TYME Stock: TYME Technologies Heads up o... | 02/03/21 |
| TYME stock is screaming for the top after announcing a patent related to COVID-19. This could be the next big short squeeze. | |
| TYME Granted U.S. Patent Claims Covering... | 02/03/21 |
| BEDMINSTER, N.J.--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-ba... | |
| Tyme Technologies (NASDAQ:TYME) Upgraded... | 11/20/20 |
| Zacks Investment Research upgraded shares of Tyme Technologies (NASDAQ:TYME) from a hold rating to a buy rating in a research note published on Thursd... | |
| Tyme Technologies Inc (NASDAQ:TYME) CEO ... | 10/24/20 |
| Tyme Technologies Inc (NASDAQ:TYME) CEO Steve Hoffman sold 37,842 shares of Tyme Technologies stock in a transaction that occurred on Thursday, Octobe... | |
| Steve Hoffman Sells 37,842 Shares of Tym... | 10/23/20 |
| Tyme Technologies Inc (NASDAQ:TYME) CEO Steve Hoffman sold 37,842 shares of the firm???s stock in a transaction that occurred on Thursday, October 22n... | |
| Michael Demurjian Sells 20,000 Shares of... | 10/21/20 |
| Tyme Technologies Inc (NASDAQ:TYME) major shareholder Michael Demurjian sold 20,000 shares of the firm???s stock in a transaction that occurred on Fri... | |
| Tyme Technologies Inc (NASDAQ:TYME) Majo... | 10/21/20 |
| Tyme Technologies Inc (NASDAQ:TYME) major shareholder Michael Demurjian sold 20,000 shares of the company???s stock in a transaction on Friday, Octobe... | |
| Insider Selling: Tyme Technologies Inc (... | 10/20/20 |
| Tyme Technologies Inc (NASDAQ:TYME) major shareholder Michael Demurjian sold 20,000 shares of the firm???s stock in a transaction on Monday, October 1... | |
| Tyme Technologies to Present at Jefferie... | 10/13/20 |
| BEDMINSTER, N.J.--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-ba... | |
| Tyme Technologies to Present at BioNJ???... | 09/14/20 |
| NEW YORK--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ:TYME), an emerging biotechnology company developing cancer metabolism-based thera... | |
| Tyme Technologies to Present at H.C. Wai... | 09/02/20 |
| NEW YORK--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based ther... | |
| CRM, HPE among premarket gainers | 08/26/20 |
| Tyme Technologies (NASDAQ:TYME) +29%. as oncology research reveals potential new oral therapy TYME-19 in the fight against COVID-19. SCWorx (NASDAQ:WO... | |
| TYME???s Oncology Research Reveals Poten... | 08/26/20 |
| BEDMINSTER, N.J.--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-ba... | |
| Tyme Technologies to Present at the 2020... | 08/21/20 |
| BEDMINSTER, N.J.--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-ba... | |
| Insider Sells Tyme Technologies's Shares | 08/18/20 |
| Tyme Technologies Inc (NASDAQ:TYME) was trading 0.7% lower from the previous closing price. A Form 4 filing filed with the SEC on Tuesday, August 18 s... | |
| Why Tyme Technologies's Stock Is Trading... | 08/03/20 |
| Tyme Technologies (NASDAQ: TYME ) shares are trading higher on Monday after the company announced an orphan drug designation for its SM-88 as a potent... | |
| TYME Announces Orphan Drug Designation f... | 08/03/20 |
| BEDMINSTER, N.J.--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-ba... | |
| Tyme Technologies to Present at Canaccor... | 07/21/20 |
| NEW YORK--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based ther... | |
| TYME Provides Business Update and Announ... | 07/13/20 |
| NEW YORK--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based ther... | |
| Tyme Technologies Announces Virtual 2020... | 07/10/20 |
| NEW YORK--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based ther... | |
| Edited Transcript of TYME.OQ earnings co... | 06/28/20 |
| Q4 2020 Tyme Technologies Inc Earnings Call | |
| TYME-18 Demonstrates Anti-Cancer Effect ... | 06/23/20 |
| NEW YORK--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based ther... | |
| TYME Presents New Preclinical Data Suppo... | 06/22/20 |
| NEW YORK--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based ther... | |
| Date | 2021-02-03 (BMO) | Est. (EPS/Rev.) | ($0.06)/ 0 |
| Actual (EPS/Rev.) | $-0.05/ | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Big Data Zhou | Zhou Academy | 82.00 % | Subscribe |
| Arbitrage Trade Analytics | Royce Wells | 72.00 % | Subscribe |
| Swing Trading Cheap Stocks <~ $10 | Michael S. DeVries | 70.00 % | Follow |
| R R Investments | Roland Van Rij | 44.00 % | Follow |
| JBloombiz1 | J Bloom | 0.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
